Page 1
About this document
This Payment Basics document explains Medicare Part D’s prescription drug benefit and payment system, including the 2026 standard benefit’s $615 deductible and $2,100 true out-of-pocket spending limit. It describes federal subsidies, plan bidding and risk adjustment, reinsurance, risk corridors, enrollee premiums, and low-income assistance. It also covers Inflation Reduction Act changes, the Part D Premium Stabilization Demonstration, inflation rebates, and Medicare drug price negotiations. Revised in November 2025, it reflects policies current as of September 30, 2025.
Free preview text
The first 5 pages, shown as text so search engines and readers can find this document.
Page 1
paymentbasics 425 I Street, NW Suite 701 Washington, DC 20001 ph: 202-220-3700 www.medpac.gov ME AC ME AC Medicare Payment Advisory CommissionPART D PAYMENT SYSTEM In 2023, Medicare spent $112.6 billion in subsidies for the Part D program. A combination of stand-alone prescription drug plans (PDPs) and Medicare Advantage (MA) prescription drug plans (MA–PDs) delivers Medicare’s voluntary outpatient drug benefit. In each of 34 geographic regions, plans compete for enrollees on the basis of annual premiums, benefit structures, specific drug therapies covered, pharmacy networks, and quality of services. Medicare aims to subsidize premiums by about 75 percent and provides additional subsidies for beneficiaries who have low income and assets.1 Medicare’s payments to plans are determined through a competitive bidding process, and enrollee premiums are tied to plan bids. Part D has several mechanisms for risk sharing so that plans do not take all the insurance risk for their enrollees’ drug spending. The drug benefit A number of changes in law have revised the structure of the Part D benefit over time, most recently under the Inflation Reduction Act of 2022 (IRA). Most of the IRA’s changes to Part D’s standard benefit began in 2025, including a single standard benefit design for all enrollees, whether receiving the low-income subsidy or not. For 2026, the standard benefit will include:2 • a $615 deductible; • coverage for 75 percent of allowable drug expenses in the initial coverage phase; and • a $2,100 limit on true out-of-pocket (OOP) spending.3 CMS updates these benefit parameters each year to reflect estimated changes in average annual drug spending. Figure 1 details each stakeholder’s liability in each phase of the reformed standard benefit. Beginning in 2025, after reaching their deductible, beneficiaries pay 25 percent cost sharing until they reach the annual OOP limit. The IRA eliminated cost sharing above the OOP limit; in 2026, beneficiaries will have no cost sharing once they have spent $2,100 out of pocket. Under Part D, individuals with low income and limited assets have lower cost-sharing liability and receive an additional premium subsidy (these individuals receive the low- income subsidy (LIS)). Beneficiaries dually eligible for Medicare and Medicaid with incomes up to 100 percent of the federal poverty level have no deductibles, nominal copays, and receive full premium subsidies. Beneficiaries who do not qualify for full Medicaid benefits but whose incomes are below 150 percent of the poverty level and who meet an asset test have no deductibles and receive full premium subsidies, but their copayments are higher than those that apply to beneficiaries who qualify for full Medicaid benefits.4 Plans can and often do offer alternative coverage structures to provide the basic Part D benefit. For example, a plan can offer a deductible lower than $615, or use tiered copayments rather than coinsurance— provided that the alternative benefit meets certain tests of actuarial equivalence. Also, plans may offer additional drug coverage through an enhanced plan that supplements the standard benefit. Medicare’s payments to plans do not subsidize such supplemental coverage, and enrollees in those plans may have to pay additional premiums.5 Medicare’s subsidy components For each enrollee in a plan (either a stand- alone PDP or MA–PD), Medicare provides plans with a subsidy that aims to average 74.5 percent of basic benefit costs for all types of beneficiaries.6 That average subsidy takes two forms: • Direct subsidy—a capitated payment to plans calculated as a share of the national average of plan bids adjusted for risk. Revised: November 2025 The policies discussed in this document were current as of September 30, 2025. This document does not reflect proposed legislation or regulatory actions.
Page 2
2 Part D payment systempaymentbasics • Individual reinsurance—Medicare subsidizes a portion of drug spending above the annual OOP limit on an incurred cost basis. (Beginning in 2025, Medicare reduced its reinsurance and increased capitated payments.) Reinsurance acts as a form of risk adjustment by providing greater federal subsidies for the highest-cost enrollees. In addition, Medicare establishes symmetric risk corridors separately for each plan in order to limit a plan’s overall losses or profits. Under risk corridors, Medicare limits a plan’s losses (or gains) by financing some of the higher-than- expected costs (or recouping higher- than-expected profits). Also, Medicare pays plans most of their LIS enrollees’ cost sharing and premiums. Note that although plans get essentially the same level of direct subsidy per enrollee (modified by risk scores), the level of other payments differs substantially from plan to plan. Other payments vary depending on the characteristics of the individuals that each plan enrolls (e.g., their income), as well as whether a plan’s losses or profits trigger provisions of its risk corridors. Part D serves as the primary source of prescription drug coverage for individuals who are dually eligible for Medicare and Medicaid. However, states continue to help finance the costs of drug coverage Figure 1 Standard drug benefit in 2026 . . . Catastrophic coverage Premium Initial coverage 25% 100% 20% 10% 60% 65% 20% Note: OOP (out-of-pocket). This benefit structure is applicable to an enrollee who has no supplementary drug coverage and is taking an "applicable drug" (i.e., a brand-name drug, biologic, or biosimilar) for which a manufacturer will owe a discount under the manufacturer discount program. For generic drugs, plan sponsors must cover 75 percent of enrollee spending between the deductible and OOP cap (with enrollees paying the remaining 25 percent), and Medicare's reinsurance will pay for 40 percent of spending in the catastrophic phase. For low-income subsidy (LIS) enrollees, Medicare's LIS pays for all cost sharing except nominal copayments. * Equivalent to $2,100 in OOP spending: $615 (deductible) + $1,485 (25 percent cost sharing on $5,940). Total spending at the annual OOP limit would depend on the mix of drugs used and whether the individual was enrolled in an enhanced plan with supplemental benefits. ** There is a base beneficiary premium of $38.99 (about $468 per year), which is less than 15 percent of expected Medicare Part D benefits per person, but the actual premiums that beneficiaries pay vary by plan. Federal subsidies pay for the remainder of covered Part D benefits. . Enrollee cost sharing and Medicare low-income cost-sharing subsidy (if applicable) Plan liability Brand manufacturer discount Medicare program $38.99 per month** Approximate total spending of $6,555 at $2,100 true OOP cap* Deductible $615
Page 3
3 Part D payment systempaymentbasics for dually eligible beneficiaries by making monthly lump-sum payments to Medicare. Medicare’s payments to plans Each plan submits a bid annually to CMS by the first Monday in June for plans that will be offered starting in January of the following year. The bid reflects the plan’s expected basic benefit costs plus administrative costs and profits after deducting expected federal reinsurance subsidies. Plans base their bids on expected costs for a beneficiary with an average risk score. The direct subsidy that CMS pays to each plan takes the form of a monthly prospective payment for each enrollee based on the plan’s approved bid. The plan bid is first adjusted by the enrollees’ diagnoses and other factors, namely low-income status and long-term institutionalized status through the prescription drug hierarchical condition category (RxHCC) risk score (Figure 2). A second adjustment to the plan’s bid is the subtraction of the enrollee’s premium. (See the following section on how premiums are calculated.) The agency reconciles payments to reflect the actual levels of enrollment, risk Figure 2 Part D payment system, 2026 . . . Note: RxHCC (prescription drug hierarchical condition category). The RxHCC is the model that estimates the enrollee risk score. CMS uses five separate sets of model coefficients for long-term institutionalized enrollees, aged low-income enrollees, aged non-low-income enrollees, disabled low-income enrollees, and disabled non-low-income enrollees. * Figure 3 outlines the process for calculating enrollee premiums. ** Plans receive interim prospective payments for individual reinsurance and low-income subsidies that are later reconciled with CMS. Plan payment =+ Risk adjustment of plan bids RxHCC risk score RxHCC Enrollee characteristics: Plan bid x Direct subsidy Enrollee premium* Plan bid adjusted for enrollee risk scores – Other payments** Risk-corridor payments Low-income subsidies Individual reinsurance Plan submits bid Diagnoses Disabled status Age Low-income status Sex Long-term institutionalized status
Page 4
4 Part D payment systempaymentbasics factors, and levels of incurred allowable drug costs (after rebates and other discounts) after the end of each year. The changes made under the IRA will cause much more of the program’s subsidy of basic benefits to take the form of capitated direct-subsidy payments rather than cost- based reinsurance payments, but Medicare’s expected overall subsidy rate remains unchanged at 74.5 percent (unless required to increase to accommodate the 6 percent cap on annual premium increases included in the IRA, discussed below). Calculating enrollee premiums CMS takes plans’ standardized bid amounts for basic benefits and calculates the average (Figure 3).7 The base premium is a share of the nationwide average bid, as detailed in the note for Figure 3. To enroll in a Part D plan, beneficiaries pay the base premium plus any difference between their plan’s bid and the nationwide average bid.8 Enrollees in costlier plans face higher-than-average premiums for basic Part D coverage; similarly, enrollees in less expensive plans pay lower-than-average premiums.9 Beginning in 2024, the IRA limits the annual increase in the base premium to no more than 6 percent. The base premium amount for beneficiaries is $38.99 per month in 2026. (Without the IRA change, the base premium amount would be $75.38 per month in 2026.) Figure 3 Calculating enrollee premiums for basic benefits, 2026 . . . Enrollee premium (Plan bid – nationwide average bid) + base premium Calculate nationwide average bid Nationwide average bid Plan 1 bid Plan 2 bid Plan 3 bid Compare plan bids to nationwide average bid Nationwide average bid Plan 1 bid Plan 2 bid Plan 3 bid Calculate enrollee premiums Nationwide average bid Base premium*Plan 1 (no premium) Plan 2 premium Plan 3 premium In this example, Plan 1’s bid is smaller than, Plan 2’s bid is equal to, and Plan 3’s bid is larger than the nationwide average bid. Calculate nationwide average bid Nationwide average bid Base premium* Plan 1 bid Plan 2 bid Plan 3 bid Compare plan bids to nationwide average bid Nationwide average bid Base premium Plan 1 bid Plan 2 bid Plan 3 bid In this example, Plan 1’s bid is smaller than, Plan 2’s bid is equal to, and Plan 3’s bid is larger than the nationwide average bid. Note: *The base premium is a share of the nationwide average bid. It equals the nationwide average times a factor with a numerator of 25.5 percent and a denominator of 100 percent minus CMS’s estimate of aggregate plan revenues for Part D benefits that plans receive through federal individual reinsurance subsidies. Beginning in 2024, the Inflation Reduction Act of 2022 limits the annual increase in the base premium to no more than 6 percent. When this provision is binding (as it has been in each year since it became applicable), the base premium's share of Part D benefit costs is less than 25.5 percent applied to the nationwide average bid amount. Beginning in 2011, Part D began collecting additional premiums from higher-income enrollees. The extra premium amount is a percentage applied to the nationwide average bid and is based on modified adjusted gross income from one's 2024 tax return.
Page 5
5 Part D payment systempaymentbasics and 2026), the base premium’s share of Part D benefit costs is less than 25.5 percent applied to the nationwide average bid amount, and, as a result, Medicare’s subsidy rate can be higher than the 74.5 percent specified in law. In addition, the premium subsidy is reduced for higher-income beneficiaries. For more information, refer to the section on calculating enrollee premiums. 2 The IRA eliminated cost sharing above the OOP limit in 2024 and, effective in 2025, eliminated the program’s former coverage gap. The IRA also made changes to plan liability, manufacturer discounts owed, and Medicare’s reinsurance liability. (See Endnote 1.) 3 The term “true out-of-pocket” (TrOOP) refers to those costs that count toward the catastrophic threshold. In addition to a beneficiary’s own OOP expenditures or payments made on behalf of the beneficiary (e.g., charity), beginning in 2025, the value of supplemental coverage provided by enhanced plans and employer group waiver plans also counts towards TrOOP. The inclusion of supplemental coverage towards TrOOP is a result of changes made by the IRA. Conversely, mandatory manufacturer discounts are no longer counted towards TrOOP, another change of the IRA. Beneficiaries need to adhere to their plan’s formulary, prior authorization, and formulary exceptions processes in order to receive credit for their OOP spending toward the $2,100 limit. 4 Starting in 2024, the IRA expanded the eligibility for the full LIS to beneficiaries who earn between 135 percent and 150 percent of the federal poverty level and meet the asset test. Prior to 2024, these beneficiaries qualified for only a partial LIS. 5 MA–PD plans may use Part C rebates to “buy down” their enrollees’ premiums, including premiums for enhanced prescription drug coverage. 6 See Endnote 1. 7 For enhanced plans, the cost for basic benefits is calculated separately from that of supplemental benefits, allowing just the portion for basic benefits to be included in this calculation. 8 Premiums for individual plans vary widely, with many MA–PDs charging $0 after applying a portion of Part C rebates to offset premium costs that MA–PD enrollees would otherwise pay. 9 Beneficiaries (other than those who receive the LIS) who delay enrolling in Part D until after their initial enrollment period and who do not have creditable coverage must also pay a late-enrollment penalty each month, similar to that for Part B. “Creditable coverage” refers to prescription drug benefits through sources such as a former employer that are at least as generous as the standard Part D benefit. 10 The first year of the demonstration in 2025 provided greater risk-corridor protection from losses. This provision was eliminated for 2026. For 2026, CMS announced that it will continue the new Part D Premium Stabilization Demonstration, a voluntary demonstration for stand-alone PDPs established in 2025 and made available for up to two subsequent years. In 2026, for participating PDPs, the demonstration would lower the monthly beneficiary premium by up to $10 and limit total monthly Part D premium (including any premium charged for supplemental benefits) increases to no more than $50.10 Individuals with modified adjusted gross incomes exceeding certain income thresholds are subject to higher premiums, similar to the income-related premium under Medicare Part B. Medicare pays all or most of the premium for low-income beneficiaries up to a regional threshold amount, calculated as an enrollment-weighted average premium for each PDP region. Mandatory rebates to Medicare for rapid price growth As a result of the IRA, all covered Part D drugs are subject to inflation rebates as of October 1, 2022. Manufacturers are required to provide rebates to the Medicare program for increases in the price of drugs sold in Part D that are greater than the increase in inflation over the same period, relative to a 2021 benchmark. The Medicare Drug Price Negotiation Program The IRA also implemented the Medicare Drug Price Negotiation Program, which requires manufacturers of selected drugs to engage in negotiations with the Secretary of Health and Human Services over prices charged under Medicare Part B and Part D. Negotiated prices for first 10 selected Part D drugs go into effect in 2026. ■ 1 As a result of the changes made by the Inflation Reduction Act of 2022, beginning in 2024, the annual increase in the base premium is limited to no more than 6 percent. When this provision is binding (as has been the case for 2024, 2025,
Tags
Doxxly editorial guide
Part D Payment System: summary, contents and background
This guide helps you understand the scope of Part D Payment System before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.
Summary and overview
Part D Payment System is a 5-page documentcredited to Soren B. Whitlock. This Payment Basics document explains Medicare Part D’s prescription drug benefit and payment system, including the 2026 standard benefit’s $615 deductible and $2,100 true out-of-pocket spending limit. It describes federal subsidies, plan bidding and risk adjustment, reinsurance, risk corridors, enrollee premiums, and low-income assistance. It also covers Inflation Reduction Act changes, the Part D Premium Stabilization Demonstration, inflation rebates, and Medicare drug price negotiations. Revised in November 2025, it reflects policies current as of September 30, 2025. It appears in the Politics & Government collection, which groups it with other material that readers may use for comparison and further study.
The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Medicare Part D, Payment Basics, Prescription drug coverage, Medicare payment policy, Inflation Reduction Act, Low-income subsidies, Drug pricing, 2026 benefits with the related resources linked below.
Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.
Key topics and reader takeaways
The catalogue connects this document with Medicare Part D, Payment Basics, Prescription drug coverage, Medicare payment policy, Inflation Reduction Act, Low-income subsidies, Drug pricing, 2026 benefits. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.
A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.
Table of contents and reading guide
The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 5 pages in the player.
- Part 1
Medicare Part D
Use this section of the reading guide to identify how Medicare Part D appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 2
Payment Basics
Use this section of the reading guide to identify how Payment Basics appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 3
Prescription drug coverage
Use this section of the reading guide to identify how Prescription drug coverage appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 4
Medicare payment policy
Use this section of the reading guide to identify how Medicare payment policy appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 5
Inflation Reduction Act
Use this section of the reading guide to identify how Inflation Reduction Act appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 6
Low-income subsidies
Use this section of the reading guide to identify how Low-income subsidies appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 7
Drug pricing
Use this section of the reading guide to identify how Drug pricing appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
- Part 8
2026 benefits
Use this section of the reading guide to identify how 2026 benefits appears in Part D Payment System, note important terms, and connect the subject to the wider purpose of the work.
When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.
About Soren B. Whitlock
Doxxly credits Soren B. Whitlock as the author or creator of Part D Payment System. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.
Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.
About the source organisation
The recorded source for this item is medpac.gov. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.
Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.
Visit medpac.govHow to read and use this document
Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.
The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.
If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.
Research questions to consider
As you read Part D Payment System, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.
A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Politics & Government collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.
Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.
Frequently asked questions about Part D Payment System
Practical answers about reading, downloading and understanding this document on Doxxly.
More in Politics & Government
- Document
Science: A New Golden Age
Umar I. Alder
- Document
City of Emeryville - Alameda County Transportation Improvement Authority Measure B 2000 Funds: Financial Statements for the Year Ended June 30, 2009
Lior Z. Fairbourne
- Document
Adaptation War - Confronting the New Adversary Learning and Adaptation Bloc
Bram D. Hollis
- Document
Counting What Counts: A Compass of Progress for People and Planet
Elias J. Fairbourne
- Document
Circular No. A-130: Managing Information as a Strategic Resource
Quill V. Grayling
- Document
DC Child Care Subsidy Program Policy Manual
Zora Z. Cressley
